[144] Enova International, Inc. SEC Filing

Rhea-AI Filing Summary

Enova International (ENVA) Form 144 notice: An officer or insider proposes to sell 35,000 shares of common stock through Merrill Lynch on the NYSE with an aggregate market value listed as $4,270,000. The shares were acquired on 02/12/2019 via a stock option from Enova International. The filing also discloses prior sales by the same person, totaling 57,000 shares sold across six transactions between 06/20/2025 and 09/04/2025, with reported gross proceeds for those sales. The filer represents they are not aware of undisclosed material adverse information and notes Rule 144 representations regarding trading plans.

Positive

• Securities were acquired via a stock option on 02/12/2019, indicating these are vested, granted awards rather than newly purchased shares

Negative

• Multiple recent insider sales disclosed (totaling 57,000 shares from 06/20/2025 to 09/04/2025) plus a proposed sale of 35,000 shares, increasing insider supply of common stock

Insights

Securities Analyst

TL;DR: Insider proposes to sell additional shares after multiple recent dispositions, which may increase supply but is presented as Rule 144-compliant.

The notice shows a proposed sale of 35,000 common shares through Merrill Lynch and documents prior disposals of 57,000 shares in the last three months with specified gross proceeds. The shares to be sold were acquired via a 2019 stock option, indicating these are previously granted, vested equity awards rather than open-market purchases. The filing includes the standard Rule 144 attestation that no undisclosed material adverse information is known to the seller.

Corporate Governance Expert

TL;DR: Multiple recent insider sales plus a new proposed sale warrant monitoring but do not alone indicate corporate problems.

The form documents repeated insider sales across June–September 2025 and a forthcoming notice to sell additional shares. Such patterns can reflect diversification or personal liquidity needs, especially when the securities originated from a company stock option granted in 2019. The filing complies with Rule 144 disclosure requirements and contains the required representation about material nonpublic information; no governance breach or corrective action is disclosed in the form itself.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Merrill Lynch 110 N Wacker Dr, Ste 1900 Chicago IL 60606	35000	4270000	25012613	09/17/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/12/2019	Stock Option	Enova International			35000	02/12/2019	Stock Option

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
David Fisher 175 West Jackson Blvd, Ste 600 Chicago IL 60604	Common	06/20/2025	2000	196762.87
David Fisher 175 West Jackson Blvd, Ste 600 Chicago IL 60604	Common	07/14/2025	5000	575951.66
David Fisher 175 West Jackson Blvd, Ste 600 Chicago IL 60604	Common	08/26/2025	5000	588801.44
David Fisher 175 West Jackson Blvd, Ste 600 Chicago IL 60604	Common	08/28/2025	15000	1826442.6
David Fisher 175 West Jackson Blvd, Ste 600 Chicago IL 60604	Common	08/29/2025	10000	1217589.22
David Fisher 175 West Jackson Blvd, Ste 600 Chicago IL 60604	Common	09/04/2025	20000	2438319.06

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for ENVA disclose about the proposed sale?

The Form 144 discloses a proposed sale of 35,000 common shares through Merrill Lynch on the NYSE with an aggregate market value of $4,270,000.

How were the shares to be sold acquired according to the filing?

The shares were acquired on 02/12/2019 via a stock option granted by Enova International.

Has the filer sold shares recently?

Yes. The filing lists six sales totaling 57,000 shares between 06/20/2025 and 09/04/2025, with reported gross proceeds for each transaction.

Through which broker will the proposed sale be executed?

The proposed sale lists Merrill Lynch, 110 N Wacker Dr, Ste 1900, Chicago, IL as the broker.

Does the filing state any undisclosed material information?

The filer represents by signing the notice that they do not know any material adverse information about the issuer that has not been publicly disclosed.

Are the securities to be sold listed on an exchange?

Yes. The filing indicates the securities are listed on the NYSE.